Uncategorized

Middle Eastern Penny Stocks To Watch In May 2026

The Middle Eastern stock markets have been experiencing a notable upswing, with Dubai leading the Gulf gains amid hopes for peace with Iran and Egypt reaching new record highs. In this context, investors are increasingly interested in exploring diverse opportunities, including penny stocks. Although the term “penny stocks” may seem outdated, these investments often refer to smaller or newer companies that can offer affordability and growth potential when backed by strong financials.

Top 10 Penny Stocks In The Middle East

Name

Share Price

Market Cap

Financial Health Rating

Alpha Data PJSC (ADX:ALPHADATA)

AED1.50

AED1.5B

★★★★★☆

Amanat Holdings PJSC (DFM:AMANAT)

AED1.27

AED3.18B

★★★★★☆

Sharjah Insurance Company P.S.C (ADX:SICO)

AED1.52

AED228M

★★★★★★

Al Wathba National Insurance Company PJSC (ADX:AWNIC)

AED3.10

AED641.7M

★★★★★★

Dubai Investments PJSC (DFM:DIC)

AED3.78

AED16.63B

★★★★★☆

Al Waha Capital PJSC (ADX:WAHA)

AED1.87

AED3.54B

★★★★★☆

Union Properties (DFM:UPP)

AED0.74

AED3.26B

★★★★★☆

Abu Dhabi National Hotels Company PJSC (ADX:ADNH)

AED0.373

AED4.72B

★★★★★★

Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)

AED1.07

AED650.83M

★★★★★☆

Tgi Infrastructures (TASE:TGI)

₪2.358

₪185.1M

★★★★★★

Click here to see the full list of 73 stocks from our Middle Eastern Penny Stocks screener.

We’re going to check out a few of the best picks from our screener tool.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Gulf Pharmaceutical Industries P.S.C., along with its subsidiaries, is engaged in the manufacturing and sale of medicines, drugs, and various pharmaceutical, cosmetic, and medical compounds across the United Arab Emirates, other GCC countries, and internationally; it has a market cap of AED1.31 billion.

Operations: The company’s revenue is primarily derived from its manufacturing segment, which accounts for AED913.1 million, followed by trading activities contributing AED432.6 million.

Market Cap: AED1.31B

Gulf Pharmaceutical Industries P.S.C. has shown significant improvement in profitability, with net income rising to AED172.2 million for 2025 from AED44.6 million the previous year, driven by strong revenue growth of AED1.08 billion. The company maintains a solid financial position with short-term assets of AED1.5 billion exceeding both short and long-term liabilities, and its debt-to-equity ratio has decreased over five years to 27.5%. However, while cash exceeds total debt, interest coverage remains a concern at 2.6 times EBIT, and return on equity is relatively low at 4.6%.

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *